Conference Coverage

International expert group agrees on redefining psoriasis severity

Publish date: December 1, 2020

 

FROM MEDSCAPELIVE LAS VEGAS DERMATOLOGY SEMINAR

MedscapeLive and this news organization are owned by the same parent company.

bjancin@mdedge.com

Pages

Recommended Reading

Biologics may protect psoriasis patients against severe COVID-19
MDedge Dermatology
Biologics in Pediatric Psoriasis and Atopic Dermatitis: Revolutionizing the Treatment Landscape
MDedge Dermatology
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis in Pediatric Patients
MDedge Dermatology
Topical tapinarof effective in pivotal psoriasis trials
MDedge Dermatology
Methotrexate users need tuberculosis tests in high-TB areas
MDedge Dermatology
Chronic inflammatory diseases vary widely in CHD risk 
MDedge Dermatology
Tildrakizumab for psoriasis shows durable efficacy over 5 years
MDedge Dermatology
TNF inhibitor–induced psoriasis treatment algorithm maintains TNF inhibitor if possible
MDedge Dermatology
Expanded indications likely for apremilast
MDedge Dermatology
The case for anti–IL-17 agents as first-line biologics in psoriatic arthritis
MDedge Dermatology